PH
IXICO plc
PHYOF · OTC
$0.07 +0.00% (+$0.00)
Market Cap £4.87M
P/E Ratio -
Div. Yield -
ROE 14.93%
Piotroski F-Score Weak
3/9Valuation
100 /100
Cheap P/B 0.41x
P/S 0.74x
EV/FFO N/A
Growth
3 /100
Declining Book val. growth 2.06%
Rev. growth 8.90%
FCF growth N/A
Profitability
19 /100
Weak Op. margin 39.09%
Gross margin 48.71%
FCF margin 28.73%
Quality
6 /100
Poor ROA 11.93%
ROIC 14.43%
Asset turnover 0.47x
Debt
69 /100
Low Int. coverage -152.06x
Debt/Equity 0.02x
Current ratio 3.03x
Stability
19 /100
Unstable EPS volatility 137.95%
Beta 0.11x
Profitable years 0
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
Vprašajte StockBota o PHYOF
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Bram Goorden
Employees
79
Headquarters
London
Prihajajoči dogodki
08 DEC.
Earnings
Upcoming earnings report